EDAP TMS SA -ADR (EDAP) Fundamental Analysis & Valuation

NASDAQ:EDAP • US2683111072

4.025 USD
-0.11 (-2.78%)
Last: Mar 12, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This EDAP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

EDAP gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. EDAP has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, EDAP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. EDAP Profitability Analysis

1.1 Basic Checks

  • EDAP had negative earnings in the past year.
  • In the past year EDAP has reported a negative cash flow from operations.
  • EDAP had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: EDAP reported negative operating cash flow in multiple years.
EDAP Yearly Net Income VS EBIT VS OCF VS FCFEDAP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

  • The Return On Assets of EDAP (-31.94%) is worse than 60.87% of its industry peers.
  • Looking at the Return On Equity, with a value of -84.17%, EDAP is in line with its industry, outperforming 40.22% of the companies in the same industry.
Industry RankSector Rank
ROA -31.94%
ROE -84.17%
ROIC N/A
ROA(3y)-16.04%
ROA(5y)-10.06%
ROE(3y)-29.27%
ROE(5y)-18.58%
ROIC(3y)N/A
ROIC(5y)N/A
EDAP Yearly ROA, ROE, ROICEDAP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

  • Looking at the Gross Margin, with a value of 43.24%, EDAP is doing worse than 65.22% of the companies in the same industry.
  • In the last couple of years the Gross Margin of EDAP has declined.
  • EDAP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-2.4%
EDAP Yearly Profit, Operating, Gross MarginsEDAP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. EDAP Health Analysis

2.1 Basic Checks

  • EDAP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for EDAP has been increased compared to 1 year ago.
  • EDAP has more shares outstanding than it did 5 years ago.
  • EDAP has a worse debt/assets ratio than last year.
EDAP Yearly Shares OutstandingEDAP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
EDAP Yearly Total Debt VS Total AssetsEDAP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • EDAP has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
  • EDAP has a Debt to Equity ratio (0.26) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.84%
EDAP Yearly LT Debt VS Equity VS FCFEDAP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 1.41 indicates that EDAP should not have too much problems paying its short term obligations.
  • EDAP has a Current ratio of 1.41. This is in the lower half of the industry: EDAP underperforms 77.72% of its industry peers.
  • A Quick Ratio of 0.97 indicates that EDAP may have some problems paying its short term obligations.
  • The Quick ratio of EDAP (0.97) is worse than 78.80% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 0.97
EDAP Yearly Current Assets VS Current LiabilitesEDAP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. EDAP Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 11.86% over the past year.
  • Looking at the last year, EDAP shows a small growth in Revenue. The Revenue has grown by 0.13% in the last year.
  • The Revenue has been growing slightly by 7.38% on average over the past years.
EPS 1Y (TTM)11.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.53%
Revenue 1Y (TTM)0.13%
Revenue growth 3Y13.31%
Revenue growth 5Y7.38%
Sales Q2Q%5.96%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.68% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 17.39% on average over the next years. This is quite good.
EPS Next Y-19.95%
EPS Next 2Y-12.27%
EPS Next 3Y0.22%
EPS Next 5Y13.68%
Revenue Next Year-3.99%
Revenue Next 2Y1.43%
Revenue Next 3Y4.25%
Revenue Next 5Y17.39%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EDAP Yearly Revenue VS EstimatesEDAP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
EDAP Yearly EPS VS EstimatesEDAP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 -0.2 0.4 -0.4 0.6 -0.6

More info and screens

Find the best growth stocksShow best growing peers

0

4. EDAP Valuation Analysis

4.1 Price/Earnings Ratio

  • EDAP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EDAP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EDAP Price Earnings VS Forward Price EarningsEDAP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EDAP Per share dataEDAP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.27%
EPS Next 3Y0.22%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EDAP Dividend Analysis

5.1 Amount

  • No dividends for EDAP!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EDAP Fundamentals: All Metrics, Ratios and Statistics

EDAP TMS SA -ADR

NASDAQ:EDAP (3/12/2026, 8:00:02 PM)

4.025

-0.11 (-2.78%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06
Earnings (Next)03-25
Inst Owners37.09%
Inst Owner Change0.56%
Ins Owners4.42%
Ins Owner Change0%
Market Cap149.34M
Revenue(TTM)63.80M
Net Income(TTM)-19.63M
Analysts77.78
Price Target6.97 (73.17%)
Short Float %0.25%
Short Ratio1.18
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.42%
Min EPS beat(2)7.96%
Max EPS beat(2)40.88%
EPS beat(4)3
Avg EPS beat(4)19.08%
Min EPS beat(4)-23.38%
Max EPS beat(4)50.84%
EPS beat(8)3
Avg EPS beat(8)-24.52%
EPS beat(12)3
Avg EPS beat(12)-303.5%
EPS beat(16)7
Avg EPS beat(16)-180.95%
Revenue beat(2)2
Avg Revenue beat(2)5.63%
Min Revenue beat(2)5.32%
Max Revenue beat(2)5.94%
Revenue beat(4)3
Avg Revenue beat(4)0.41%
Min Revenue beat(4)-12.67%
Max Revenue beat(4)5.94%
Revenue beat(8)4
Avg Revenue beat(8)-1.45%
Revenue beat(12)5
Avg Revenue beat(12)-3.55%
Revenue beat(16)7
Avg Revenue beat(16)-1.94%
PT rev (1m)0%
PT rev (3m)17.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.11%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.61%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.03
P/FCF N/A
P/OCF N/A
P/B 5.55
P/tB 6.19
EV/EBITDA N/A
EPS(TTM)-0.6
EYN/A
EPS(NY)-0.73
Fwd EYN/A
FCF(TTM)-0.51
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS1.99
BVpS0.73
TBVpS0.65
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -31.94%
ROE -84.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.24%
FCFM N/A
ROA(3y)-16.04%
ROA(5y)-10.06%
ROE(3y)-29.27%
ROE(5y)-18.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-2.4%
F-Score4
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 189.75%
Cap/Sales 7.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 0.97
Altman-Z N/A
F-Score4
WACC7.84%
ROIC/WACCN/A
Cap/Depr(3y)176.18%
Cap/Depr(5y)116.88%
Cap/Sales(3y)5.91%
Cap/Sales(5y)4.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.53%
EPS Next Y-19.95%
EPS Next 2Y-12.27%
EPS Next 3Y0.22%
EPS Next 5Y13.68%
Revenue 1Y (TTM)0.13%
Revenue growth 3Y13.31%
Revenue growth 5Y7.38%
Sales Q2Q%5.96%
Revenue Next Year-3.99%
Revenue Next 2Y1.43%
Revenue Next 3Y4.25%
Revenue Next 5Y17.39%
EBIT growth 1Y-0.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.69%
EBIT Next 3Y3.38%
EBIT Next 5YN/A
FCF growth 1Y6.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.45%
OCF growth 3YN/A
OCF growth 5YN/A

EDAP TMS SA -ADR / EDAP FAQ

What is the fundamental rating for EDAP stock?

ChartMill assigns a fundamental rating of 1 / 10 to EDAP.


Can you provide the valuation status for EDAP TMS SA -ADR?

ChartMill assigns a valuation rating of 0 / 10 to EDAP TMS SA -ADR (EDAP). This can be considered as Overvalued.


How profitable is EDAP TMS SA -ADR (EDAP) stock?

EDAP TMS SA -ADR (EDAP) has a profitability rating of 1 / 10.


What is the earnings growth outlook for EDAP TMS SA -ADR?

The Earnings per Share (EPS) of EDAP TMS SA -ADR (EDAP) is expected to decline by -19.95% in the next year.